Abstract | OBJECTIVES: MATERIALS AND METHODS: Thirty C57BL/6N mice were randomly divided into three groups (N = 10). All animals were subjected to bilateral ovariectomy (OVX) and then treated with saline (Veh), zoledronic acid (ZA), or concomitant zoledronic acid and dexamethasone (ZA/Dx) for 12 weeks. Eight weeks after starting drug administration, pulpal exposure was conducted on the lower left first molar. Four weeks after pulpal exposure, all mice were sacrificed and the mandibles were collected for radiological and histological examinations. RESULTS: Microcomputed tomography (μ-CT) examination showed significantly reduced periapical bone resorption in the ZA/Dx group and decreased periodontal bone resorption in both ZA and ZA/Dx groups. Higher bone mineral density (BMD) and strengthened microstructure were found in ZA and ZA/Dx groups. More empty lacunae were found in ZA and ZA/Dx groups. CONCLUSIONS:
|
Authors | Nian Jing Rao, Ru Qing Yu, Jing Yi Wang, Alexandra Helm, Li Wu Zheng |
Journal | BioMed research international
(Biomed Res Int)
Vol. 2019
Pg. 1271492
( 2019)
ISSN: 2314-6141 [Electronic] United States |
PMID | 31662968
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Nian Jing Rao et al. |
Chemical References |
- Bone Density Conservation Agents
- Zoledronic Acid
- Dexamethasone
|
Topics |
- Alveolar Bone Loss
(diagnostic imaging, drug therapy, pathology)
- Animals
- Bone Density
(drug effects)
- Bone Density Conservation Agents
(therapeutic use)
- Dexamethasone
(pharmacology)
- Disease Models, Animal
- Female
- Mandible
(drug effects)
- Mice
- Mice, Inbred C57BL
- Molar
(drug effects)
- Osteonecrosis
(drug therapy)
- Ovariectomy
- Periapical Diseases
(diagnostic imaging, drug therapy, pathology)
- X-Ray Microtomography
- Zoledronic Acid
(therapeutic use)
|